Target intelligence / Profile preview

Salmonella enterica subspecies enterica serovar Typhi (S. Typhi)

Target
S. Typhi
Molecular classification
Bacterium, Gram-negative bacillus, Enterobacteriaceae family
01

Overview

Salmonella enterica subspecies enterica serovar Typhi is a Gram-negative, rod-shaped, flagellated, facultatively anaerobic bacterium in the family Enterobacteriaceae[1][5]. It is the causative agent of typhoid fever, a systemic infectious disease characterized by sustained fever, abdominal pain, and sometimes a rash[7]. S. Typhi invades the intestinal epithelium, survives in phagocytes, and disseminates throughout the lymphatic system and bloodstream. It expresses distinct antigens (O, H, and Vi), with the Vi antigen being a capsule associated with increased virulence and immune evasion[1][7]. Transmission occurs via the fecal–oral route, predominantly through contaminated food and water. S. Typhi infection is treated with antibiotics, though resistance is an increasing concern, especially in endemic areas[4][6].

Other names
Salmonella TyphiS. TyphiTyphoid bacillus
02

Mechanism of action

Antibiotics inhibit bacterial DNA gyrase (fluoroquinolones)[3] Beta-lactams disrupt cell wall synthesis (penicillins, cephalosporins)[5] Macrolides inhibit protein synthesis (azithromycin)[5]

03

Biological functions

Pathogen (causes typhoid fever)host cell invasionintracellular proliferationbiofilm formation
04

Disease associations

Infection (specifically typhoid fever)enteric feversepticemiacarrier state
05

Safety considerations

Multidrug resistanceemerging extensively drug-resistant (XDR) strainschronic carriage leading to transmissionlack of effective vaccines in some regions[4][6]
06

Interacting drugs

Ciprofloxacin

5 more in the full profile.

07

Biomarkers

Vi antigen (polysaccharide capsule)[7]O antigenH antigen

Beyond the preview

Go deeper on Salmonella enterica subspecies enterica serovar Typhi (S. Typhi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica subspecies enterica serovar Typhi (S. Typhi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call